Showing results (41-50 of 227) with videos related to

Sort By:
Pageof 23
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2006
Noninvasive monitoring of long-term lentiviral vector-mediated gene expression in rodent brain with bioluminescence imagingChristophe M Deroose, Veerle Reumers, Rik Gijsbers, et al.
Nuclear Medicine and Biology|July 20, 2005
Development and biological evaluation of 99mTc-BAT-tropane estersHubert P Vanbilloen, Davy Kieffer, Bernard J Cleynhens, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2010
Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivoKoen Van Laere, Cindy Casteels, Isabel Dhollander, et al.
Neurobiology of Aging|April 5, 2011
Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivoKoen Van Laere, Cindy Casteels, Sophie Lunskens, et al.
Synapse (New York, N.Y.)|March 27, 2010
Influence of chronic bromocriptine and levodopa administration on cerebral type 1 cannabinoid receptor bindingCindy Casteels, Bert Vanbilloen, Dorien Vercammen, et al.
Headache|November 15, 2011
Interictal type 1 cannabinoid receptor binding is increased in female migraine patientsBart J Van der Schueren, Koen Van Laere, Nathalie Gérard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2013
Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosaCindy Casteels, Nathalie Gérard, Kris van Kuyck, et al.
Pharmaceutics|October 23, 2021
D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide TherapyKaat Luyten, Tom Van Loy, Christopher Cawthorne, et al.
Neurology|December 20, 2013
PET imaging shows loss of striatal PDE10A in patients with Huntington diseaseRawaha Ahmad, Sophie Bourgeois, Andrey Postnov, et al.
Pageof 23